Chemours Co
$ 21.02
9.17%
11 Feb - close price
- Market Cap 2,885,420,000 USD
- Current Price $ 21.02
- High / Low $ 21.09 / 19.44
- Stock P/E N/A
- Book Value 1.99
- EPS -2.13
- Next Earning Report 2026-02-19
- Dividend Per Share $0.68
- Dividend Yield 3.57 %
- Next Dividend Date -
- ROA 0.03 %
- ROE -0.66 %
- 52 Week High 19.99
- 52 Week Low 9.01
About
Chemours Co (Ticker: CC) is a prominent global leader in high-performance chemical solutions, focusing on titanium technologies and fluoroproducts. Headquartered in Wilmington, Delaware, the company operates across diverse regions including North America, Europe, and Asia Pacific, ensuring a robust market presence and broad customer reach. Committed to sustainability and innovation, Chemours leverages advanced technologies to deliver impactful products while prioritizing environmental stewardship. With a strategic emphasis on specialty chemical solutions, Chemours is poised for continued growth across multiple key industries.
Analyst Target Price
$16.33
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-05 | 2025-11-04 | 2025-08-05 | 2025-05-06 | 2025-02-18 | 2024-11-04 | 2024-08-01 | 2024-04-30 | 2024-03-27 | 2023-10-26 | 2023-07-27 | 2023-04-27 |
| Reported EPS | 0 | 0.2 | 0.58 | 0.13 | 0.11 | 0.4 | 0.38 | 0.32 | 0.31 | 0.63 | 1.1 | 0.98 |
| Estimated EPS | 0.0774 | 0.24 | 0.46 | 0.2 | 0.16 | 0.28 | 0.57 | 0.18 | 0.25 | 0.69 | 1.07 | 0.47 |
| Surprise | -0.0774 | -0.04 | 0.12 | -0.07 | -0.05 | 0.12 | -0.19 | 0.14 | 0.06 | -0.06 | 0.03 | 0.51 |
| Surprise Percentage | -100% | -16.6667% | 26.087% | -35% | -31.25% | 42.8571% | -33.3333% | 77.7778% | 24% | -8.6957% | 2.8037% | 108.5106% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-19 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.0 |
| Currency | USD |
Previous Dividend Records
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2025-12-15 | 2025-09-12 | 2025-06-16 | 2025-03-14 | 2024-12-16 | 2024-09-13 | 2024-06-14 | 2024-03-15 | 2023-12-15 | 2023-09-15 |
| Amount | $0.0875 | $0.0875 | $0.0875 | $0.25 | $0.25 | $0.25 | $0.25 | $0.25 | $0.25 | $0.25 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CC
2026-02-10 07:00:01
Chemours Co stock reached a 52-week high of $18.47, reflecting strong investor confidence and significant gains over the past six months despite the company operating with substantial debt. Analysts predict profitability this year, with an EPS of $0.91. Recent corporate actions include selling a former manufacturing site for $360 million and executive appointments, alongside varied price targets from BMO Capital and Truist Securities.
2026-02-09 16:58:51
Chemours Co (CC) stock recently hit a 52-week high of $18.47 USD, showing significant investor confidence despite the company operating with significant debt and not being profitable in the last year. Analysts are optimistic about future profitability, forecasting an EPS of $0.91 for the current year. The company is actively making strategic moves, including the sale of a manufacturing site for approximately $360 million and key leadership appointments, while analysts offer varied price targets reflecting market dynamics.
2026-02-07 07:57:40
Chemours (CC) has seen a significant share price rebound recently, though it trades above analyst targets but with a high estimated intrinsic discount. While a cash flow-based valuation suggests it's overvalued at $18.32 compared to a fair value of $16.33, its low P/S ratio compared to the industry indicates a potential valuation mismatch that could either be a margin of safety or a sign of future challenges. Investors are encouraged to consider the full narrative, potential risks like PFAS litigation, and other valuation metrics to form their own conclusions.
2026-02-06 11:00:01
The New York State Common Retirement Fund significantly increased its stake in The Chemours Company (NYSE:CC) by 1,085.8% in Q3, acquiring 425,642 additional shares to reach a total of 464,842 shares valued at approximately $7.36 million. Despite this increased institutional interest, analysts maintain a "Hold" consensus rating with an average price target of $16.67. Chemours recently reported mixed financial results, with revenue aligning with expectations but EPS missing forecasts, and the stock is currently trading near its 12-month high.
2026-02-05 21:28:42
Chemours Co (CC) shares recorded a yield above the 2% mark, based on its quarterly dividend. The article highlights the importance of dividends for total stock market returns, using an example of the iShares Russell 3000 ETF, and suggests that a sustainable 2% yield for Chemours would be attractive. The article also mentions Chemours Co's status as a Russell 3000 member.
2026-02-05 12:28:28
The Chemours Company (NYSE: CC) announced its plans to issue fourth quarter 2025 financial results after market on Thursday, February 19, 2026. A conference call to discuss these results will be held at 8:00 a.m. Eastern Time on Friday, February 20, 2026. The webcast and accompanying materials will be accessible through the "Events and Presentations" section of Chemours' investor relations website.
